The association of cystic fibrosis (CF) with airways infection, particularly with organisms such as Staphylococcus aureus and Pseudomonas aeruginosa, has long been recognized [1] . Chronic bacterial bronchitis is thought to result in progressive deterioration of lung function [1] [2] [3] . Following elucidation of the defect in the CFTR gene, rapid progress has been made in understanding the cellular and molecular defects associated with CF [4, 5] . The early events leading to establishment of lung infection and bronchitis, however, are still not well defined. One hypothesis is that abnormalities in CFTR function and ion transport in airway epithelium lead to obstruction of the airways by viscous secretions, which in turn predispose to persistence of bacterial infection and chronic inflammation. These processes ultimately result in irreversible damage to the airways and lung parenchyma [2, 3, 5] .
Two important observations have led recently to interest in the specific role of inflammation in the pathogenesis of CF lung disease. In a randomized, placebo-controlled trial, chronic use of high-dose ibuprofen was associated with a significant slowing of the rate of decline in lung function of CF patients, particularly in children [6] . In addition, levels of both neutrophils and the neutrophil-chemotactic cytokine interleukin (IL)-8 were elevated in bronchoalveolar lavage fluids (BALF) from some infants with CF compared with levels in disease controls, even in the absence of detectable infection [7] . These results suggested that excessive or persistent inflammation may play an independent role in the deterioration of lung function in CF and that persistent airway inflammation may be present at very early ages in children with CF.
Excessive inflammation in the airways might be due to persistence of stimuli for cytokine production (e.g., bacteria) or constitutive abnormalities in the regulation of cytokine production by airway cells (or both). Several cytokines may have specific relevance to CF: IL-8, which accounts for much of the neutrophil chemotactic activity in CF sputum [8] ; IL-lO, an antiinflammatory cytokine that may be relatively down-regulated in CF airway cells [9] ; and IL-6, a generally proinflammatory peptide that can be produced by human airway epithelium stimulated by infectious agents [10] .
Nasal respiratory epithelium shares the histologic characteristics and the ion transport abnormalities of bronchial epithelium in persons with CF [11] . We hypothesized that if baseline abnormalities in epithelial cytokine production occur in early CF, they should be manifested in nasal and lower airways. We also hypothesized that inflammation and cytokines provoked by bacterial infection in the lower airways are elevated in children with CF compared with controls. The principal goals of this study were to compare concentrations of cytokines (IL-8, IL-6, and IL-I0) in nasal lavage fluids (NLF) of controls and children with CF and to compare cytokine levels in BALF from children with CF and from control children in the absence and the presence of bacterial airway infection.
Methods
Study population and design. Over a l-year period (January 1995 to January 1996), all children with or without CF undergoing flexible fiberoptic bronchoscopy and bronchoalveolar lavage (BAL) for clinical indications were considered for inclusion in this study. Exclusion criteria were known immunodeficiency or use of systemic antiinflammatory agents (corticosteroids or nonsteroidal antiinflammatory drugs) or topical (inhaled or nasal) corticosteroids within 2 weeks before bronchoscopy. For nasal lavage, further exclusion criteria were nasal polyps or recent intubation of the nasal passage. All children with CF were diagnosed by clinical criteria, including an abnormal sweat chloride (Gibson-Cooke iontophoresis) test at an accredited CF treatment center, or by genotype. Over the study period, 28 children with CF were eligible for the study; 1 declined participation, leaving a total of 27 children with CF. Two of these children underwent bronchoscopy twice during the period of study, and a third underwent separate lavages from the right and left lungs during a single procedure. For these 3 CF children, 1 of the 2 available BALF specimens was randomly chosen for inclusion in the study analysis. Of 31 children eligible as non-CF controls, 4 declined participation, leaving 27 controls.
After sedation for bronchoscopy and prior to placement of instruments or medications in the nose, children underwent a unilateral 6-mL nasal lavage with sterile normal saline solution, using a soft rubber bulb syringe, in the lateral recumbent position as previously described [12] . Bronchoscopy was then done in the usual fashion, with the choice of location and volume of BAL made by the clinician performing the procedure. BAL was done by gently wedging the tip of the bronchoscope into the selected site and instilling two or three 10-mL aliquots of sterile nonbacteriostatic saline. Fluid was aspirated into a sterile suction trap following each aliquot, and all aliquots were pooled. The entire BAL procedure lasted <1 min. Following completion of bronchoscopy, venipuncture was done to obtain serum for urea measurements.
Processing of specimens. Before specimens were transported to the microbiology laboratory, an aliquot of BALF was taken from the specimen trap aseptically, and NLF and BALF were immediately processed in the bronchoscopy laboratory. Cells were counted by hemocytometry and an aliquot of unprocessed lavage fluid was saved for determination of cell differentials. The remainder of the unprocessed sample was centrifuged to separate supernatant from cells; for BALF, centrifugation was also done through a cell strainer (70-J.Lm pore size; Becton Dickinson, Lincoln Park, NJ) to remove mucus debris. Aliquots of cell-free supernatant were immediately placed on dry ice for transport; they were stored at -80°C until used in mediator assays.
Microbiologic studies on BALF were done in the University of North Carolina Hospitals Clinical Microbiology laboratory as ordered by the clinician performing the bronchoscopy. Quantitative bacterial culture of BALF specimens was done by spread-plating 50 J.LL each of undiluted fluid and fluid diluted 1:100 in PBS onto 5% horse blood agar, colistin-nalidixic acid agar (for recovery of gram-positive organisms), and MacConkey agar. In addition, 50 J.LL of BALF obtained from CF patients was plated on mannitol salts agar for recovery of S. aureus and PC agar for recovery of Burkholderia cepacia. Plates were incubated at 35°C in 5% CO 2 for 24-72 h before quantitation of bacterial colonies. Organisms were identified by use of standard techniques [13] . BALF specimens were also cultured for viruses, fungi, and mycobacteria according to previously described methods [13] [14] [15] .
Assays. For cell differential determination, aliquots of lavage fluid containing 0.5-2.0 X 10 5 cells were cytocentrifuged (Cytopro 7620; Wescor, Logan, UT) onto glass slides and then fixed and stained using modified Wright's stain (LeukoStat; Fisher Diagnostics, Pittsburgh). Differentials were then determined by microscopic evaluation of200 consecutive cells examined at 400X magnification. The investigator performing the differential counts (T.L.N.) was unaware ofBALF culture results at the time differential slides were evaluated. Cytokine concentrations in lavage fluids were measured by ELISA (R&D Systems, Minneapolis) according to the manufacturer's instructions. Cytokine concentrations in lavage fluids were quantitated by comparison with a standard curve generated using the appropriate recombinant human cytokine (r > .98 for all assays). The specific ELISA kits used were IL-8 (sensitivity, 3.0 pg/mL; dynamic range, 94-6000), IL-lO (sensitivity, 1.5 pg/mL; dynamic range, 7.8-500), and IL-6 (sensitivity, 3.5 pg/mL; dynamic range, 31.2-2000) . Samples with values above the dynamic range of the assay were diluted and assayed again.
Urea in lavage fluids and serum was measured spectrophotometrically using a previously described method [16] in which urea is hydrolyzed by urease to generate ammonia, which is then transferred by glutamate dehydrogenase to a-ketoglutarate. This reaction is accompanied by oxidation ofNADH to NAD. Sample urea concentrations were extrapolated from a curve generated using known quantities of urea standard. Assays were done in duplicate or triplicate. All chemicals for the urea assay were from Sigma (St. Louis). Dilution of epithelial lining fluid in the respiratory tract by lavage fluid was estimated using the ratio of lavage urea to serum urea as the dilution factor. Urea was measured in all lavage fluids, but the parents of some children refused to allow venipuncture for obtaining matching sera at the time of lavage procedures. Variability in serum urea among subjects for whom blood samples were available was relatively low compared with variability in lavage fluid urea, and it did not differ significantly (P = .33) between controls (1.55 ± 0.14 rnM; n = 18) and CF subjects (2.0 ± 0.31 rnM; n = 13). Dilution factors in children for whom serum was unavailable were estimated using the mean urea concentration for all assayed sera (1.75 mM).
Albumin was measured in lavage fluids by ELISA as previously described [17] , using a rabbit anti-human albumin primary antibody and an alkaline phosphatase-conjugated goat anti-rabbit secondary antibody (Cappel Research Products, Durham, NC). Quadruplicate measurements were averaged for the final result.
Statistical analysis. Data were analyzed statistically using either the Mann-Whitney U test (for 2-group comparisons) or the Kruskal-Wallis nonparametric analysis of variance with Dunn's post-testing (for multiple group comparisons). Correlations were analyzed using Spearman's rank correlation test. Statistical significance was defined as P < .05.
Results
Subjects. Clinical characteristics of the study population are summarized in table 1. The most frequent indications for bronchoscopy among control subjects were upper airway obstruction, recurrent or chronic pneumonia, and recurrent or chronic wheezing. The most common indications for bronchoscopy among CF patients were exacerbation of pulmonary symptoms in patients unable to produce sputum for culture or (1) Bronchitis (27) Tracheo-bronchomalacia (3) Laryngomalacia (2) Normal airways (2) * Median (range). t Some subjects had multiple indications or diagnoses.
pulmonary disease in newly diagnosed CF patients unable to produce sputum for culture. Bronchoscopic diagnoses among control children consisted mainly of anatomic abnormalities; only 48% had evidence of bronchitis (mucosal erythema and friability, excessive secretions). All but 2 CF subjects (93%) had evidence of bronchitis.
Nasal lavage data. NLF was obtained during 21 of 27 control procedures and 21 of 27 CF procedures. The volume instilled for nasal lavages was uniform (6 mL) throughout the study. There was no significant difference between control and CF subjects in the percent return of NLF (controls: median, 77%; range, 20%-92%; CF patients: median, 50%; range, 20%-87%) nor the dilution of epithelial lining fluid by lavage fluid as estimated by the urea method (controls: median, 19.3-fold dilution; range, 6.6-to 603-fold; CF patients: median, 20.9-fold dilution; range, 8.1-to llO-fold; P = .97). Albumin levels in NLF also did not differ significantly between controls (median, 8.1 p,g/mL; range, 3.6-59.8) and CF subjects (median, 14.9 p,g/mL; range, 3.2-114.6; P = .49).
In some NLF, numbers of cells were too low to permit adequate enumeration or determination of differentials (or both). Of the 21 NLF samples obtained from controls, adequate cell counts were available for 19 and differentials for 15; of 21 NLF samples from CF subjects, adequate cell counts were available for 20 and differentials for 18. NLF cell counts and differentials were not significantly different between control and CF subjects, although on average, the proportion of neutrophils was somewhat lower and the proportion of epithelial cells was higher in children with CF than in controls (table 2) .
There were no statistically significant differences in concentrations of IL-8, IL-6, and IL-10 in NLF between CF patients and controls, regardless of the method of quantitation used (table 3) .
BAL data. One of the goals of this study was to compare inflammatory mediator levels in children with CF with those in non-CF controls in the presence of bacterial infection. The lungs were considered unlikely to be infected with bacterial pathogens when colony counts of bacteria other than oropharyngeal flora were < I X 10 4/mL of BALF; lungs were considered likely to be infected when bacterial counts were~5 X 104/mL of BALF [18] [19] [20] . BALF specimens having bacterial counts of between 1 and 5 X 10 4 cfu/mL were considered to be indeterminate regarding infection of the lower respiratory tract and were excluded from analysis. Three of the 27 control BALF specimens and 2 of the 27 CF BALF specimens were indeterminate. On this basis, BALF specimens were classified after quantitative bacterial culture as belonging to children in 1 of 4 groups: uninfected control (N-), infected control (N +), uninfected CF (CF-), or infected CF (CF+) groups. Age did not differ significantly among the groups (P = .81).
The median volume of BALF instilled (20 mL for all 4 groups) and the median percent return of BALF (N-= 40%, N + = 42%, CF-= 50%, and CF+ = 37%) did not differ significantly among the 4 groups. Dilution of epithelial lining fluid by BALF as estimated by the urea method did not differ between controls (median, 45-fold dilution; range, 8-to 433-fold) and CF patients (median, 53-fold dilution; range, 9-to 237-fold; P = .89). BALF albumin levels also did not differ significantly among the 4 groups (P = .09), but on average, they were higher among infected than noninfected subjects (N-: median, 15.6 p,g/mL; range, 6.7-42.1; N+: median, 36.5 p,g/mL; range, 5.9-66.8; CF-: median, 12.6 p,g/mL; range, 5.4-33.4; CF+: median, 19.5 p,g/mL; range, 9.5-166.8).
Among controls, 12 of24 analyzed BALF samples were Nby the criteria described above. Viral cultures were done for only 2 of 12 subjects in the N-group, and they were negative. Fungal and mycobacterial cultures were done for only 3 of 12 subjects in the N-group; the cultures were negative except for a few colonies of fungus in 1 subject's BALF specimens. Among children with CF, 10 of the 25 BALF specimens were CF-. All of these CF-specimens were also negative for viruses by standard cultures, although in some, a small number of colonies of various fungal species were isolated. One of the 10 CF-BALF specimens was negative by acid-fast bacilli smear but had a positive mycobacterial culture (Mycobacterium avium-intracellulare complex).
Results for the quantitative bacterial cultures for the N + and CF+ subjects are shown in table 4. Among controls, the most common bacterial pathogens were Moraxella catarrhalis (n = 7) and Haemophilus influenzae (n = 4). Eighteen of the 30 BALF specimens from CF patients were infected with bacterial pathogens. As expected, bacterial cultures in CF patients most commonly contained S. aureus (n = 6), H. influenzae (n = 6), and P. aeruginosa (n == 4); 1 infected CF subject also had a culture positive for enterovirus, and another had a smear positive for acid-fast bacilli (table 4) . Although a broad range of bacterial colony counts was observed in both control and CF subjects, there was a trend toward higher bacterial colony counts among CF+ than among N+ samples (10/15 with> 10 6 cfu/mL ofBALF vs. 3/12 with >10 6 cfu/mL ofBALF). Table 5 shows cell counts and differentials for the 4 BALF subgroups. On average, they were quite similar for CF-and than among controls (N+ = 0.15 X 10 6/mL, N-= 0.14 X 10 6/mL). Table 6 shows BALF IL-8 concentrations among the 4 groups. Compared with levels of IL-8 in N -and N + BALF specimens, IL-8 in CF + BALF specimens was markedly elevated, regardless of the method of quantitation used (table 6) . The relationships between inflammation and bacterial pathogens or colony counts were therefore explored in more detail among the infected BALF specimens.
Within the CF + group, there were no significant differences among BALF IL-8 levels associated with any ofthe 3 predominant pathogens, H influenzae, S. aureus, or P. aeruginosa (P = .89). Although no controls had P. aeruginosa and only 1 had S. aureus in BALF, several patients from both the N + and CF + groups had H influenzae as the sole bacterial pathogen.
Comparison of data from subjects with H. influenzae alone revealed that the median IL-8 concentration for controls was 5141 pg/mL (range, 114-6224; n = 3) versus 9584 pg/mL (range, 4585-71,100; n = 5) for CF patients; however, this difference was not statistically significant (P = .39).
Quantitation of bacteria in BALF specimens was not carried out to levels> 10 6 cfu/mL. Figure lA, C shows plots of BALF neutrophil counts or IL-8 levels versus bacterial colony counts (regardless of bacterial pathogen) for all subjects with quantified (i.e., < 10 6 cfu/mL) bacterial counts in BALF, including those with intermediate bacterial counts. Although considerable overlap was observed, there was a trend for both neutrophil counts and IL-8 levels to be higher in CF patients than in controls for a given quantity of bacteria. Figure 1B , D shows that for BALF specimens having> 10 6 cfu/mL, CF subjects also tended to have higher IL-8 and neutrophil levels than non-CF controls. BALF IL-8 among CF-patients tended to be intermediate between N -and CF+ values, though this group did not differ significantly from levels in the N -group except when IL-8 levels were expressed as a ratio to albumin (table 6). Of the 10 children in the CF-group, none had received antibiotics in the 48 h preceding bronchoscopy, but most had received antibiotics during NOTE. Data are median (range). Infected was defined as~5 X 10 4 cfu/mL bacterial pathogens in BALF; uninfected was defined as <1 X 10 4 cfu/mL. P < .05 vs. * uninfected controls, t infected controls, and t uninfected CF patients (Kruskal-Wallis nonparametric analysis of variance with Dunn's post-tests).
the 2 weeks prior to bronchoscopy because of respiratory symptoms. Uninfectedchildren with CF receivingantibiotics within the 2 weeks immediately precedingbronchoscopy had median BALF IL-8 levels of 3146 pg/ml, (range, 1504-11,196; n = 8), whereas the 2 uninfected CF subjects with no recent antibiotics had levels of only 336 and 474 pg/ml., respectively. BALF IL-6 levels were significantly increased in the N+, CF-, and CF+ groups compared with levels in the N -controls, although the data among the 4 groups overlapped considerably (table 6 ). The statistical significance of intergroup comparisons varied according to the method of quantitation. In contrast to levels of IL-8, IL-6 levels between the CF+ and N + groups were not significantly different. BALF IL-I0 did not differ significantly among the 4 groups, regardless of the method of data quantitation (table 6) .
Correlations between lavage cytokines and inflammatory cells. For CF subjects, there was no intra-individual correlation between IL-8 levels in NLF and BALF (Spearman's r = -.14, P = .52). However, IL-8 levels in all lavage fluids (NLF and BALF, controls and CF patients) showed strong correlation with neutrophil counts (Spearman's r = .85, P < .0001) (figure 2). A weaker but still significant positive correlation was found between IL-6 levels and neutrophil counts (Spearman's r = .53, P < .0001) and between IL-l 0 levels and neutrophil counts (Spearman's r = .39, P < .0001). For all three cytokines, correlation with neutrophil counts was stronger for CF lavage fluids than for control lavage fluids.
Discussion
Excessive neutrophil-dominated inflammation has been observed in the lower airways early in CF, independent of infection [7] . This might be explained by overproduction of neutrophil-attracting factors (i.e., IL-8) or underproduction of antiinflammatory factors (i.e., IL-I0) by airway cells [9] . Since the epithelial ion transport abnormalities characteristic of CF are present in the nasal and bronchial airways [11], we hypothesized that nasal inflammation would also be increased in CF. However, our data show that in nasal lavage fluids, neither inflammatory cell counts nor the levels of cytokines IL-8 and IL-6 differed between children with CF and disease controls. There was an overall trend for nasal IL-I0 levels to be lower in CF than in control subjects, although the difference was not significant (P > .05) (table 3). Because of the known technical difficulties in accurately measuring solute concentrations in respiratory lining fluids [21, 22] , we analyzed lavage fluid cytokine data using several independent, previously described methods of quantitation [21] [22] [23] . Similar relationships were noted between control and CF cytokines in NLF whether data were unstandardized, standardized for subject weight and lavage volume, corrected for dilution of epithelial lining fluid by lavage fluid using the urea method, or standardized to albumin concentrations. It is thus unlikely that differences between controls and CF patients could have been undetected due to methods used for quantitation of lavage solutes.
The controls in this study were undergoing bronchoscopies because of respiratory symptoms and might, therefore, have been abnormal with regard to nasal inflammation. However, the values we obtained for NLF cell counts, percent neutrophils, and levels of IL-8 and IL-6 in the current study were similar to baseline values reported in our previous study of healthy children, which used the same lavage technique and involved similarly aged children [12] . Cultures were not performed on Table 6 . BALF cytokine concentrations for uninfected controls, infected controls, uninfected CF patients, and infected CF patients.
Controls
CF patients
* p < .05 vs uninfected and infected controls.
t Standardized by subject weight and volume of lavage fluid instilled. +ELF = epithelial lining fluid (determined by urea method). § 1 infected CF subject had insufficient sample for albumin assay, thus n = 14. II 1 subject had insufficient sample remaining to assay IL-6 in each of infected control and infected and uninfected CF patient groups.
P < .05 vs uninfected controls.
NLF in this study due to anticipated high rates of nasopharyngeal carriage of bacteria in children under normal circumstances [24] and the lack of established quantitative culture standards for differentiating colonization from infection in the nose. However, NLF inflammatory markers in the current study were much lower than the values we previously reported in normal children with acute upper respiratory infections [12] . These considerations, along with the lack of correlation between individual subjects' NLF and BALF inflammatory markers in the present study, suggest that factors responsible for excessive inflammation are confined to the lower airways early in CF and that nasal lavage fluid is a poor indicator for BALF inflammation markers in this population. Although, to our knowledge, this is the first study to measure nasal inflammation in young children with CF, Danel et al. [25] recently reported no difference in neutrophil numbers in nasal brush biopsies but significantly elevated numbers of neutrophils in lower airway brushings in adults with CF compared with healthy controls. There are few pediatric or CF data available on which to base a cutoff for BALF bacterial colony counts indicative of lower respiratory infection. On the basis of adult studies of quantitative BALF microbiology [18] [19] [20] , we chose a lower limit of 5 X 10 4 bacterial cfulmL to differentiate children likely to have true lower airway infection from those likely to have BALF contaminated from the upper airway. Bacterial lower airway infection in children with CF thus defined was associated with markedly increased IL-8 levels and neutrophil-dominated inflammation compared with N -and N + controls (tables 5, 6). The same result was found if 1 X 10 4 cfulmL was used as the lower limit for lower respiratory infection. This relationship between results for N + and CF + BALF specimens was evident regardless of whether IL-8 data were standardized for subject weight and lavage volume, corrected for dilution by the urea method, or standardized to albumin concentrations in BALF (table 6) . Although IL-6levels tended to be increased in both infected and uninfected CF subjects compared with levels in N -controls, the significance of this increase varied depending on the method used to quantify levels (table 6). In contrast to the data for IL-8, a relatively elevated IL-6 response to infection among CF patients (N + vs. CF +) was not found.
Increased BALF IL-8 in the presence of infection might be explained by differences in either specific bacterial pathogens or bacterial quantity in the airways of children with CF rather than by underlying abnormalities in inflammatory responses.
However, further comparisons between N + and CF + data based on standardization for pathogen (H. infiuenzae) and for bacterial colony counts (figure 1) suggested that BALF IL-8 levels associated with a given type or severity of bacterial infection are markedly increased in children with CF compared with disease controls. Because limited numbers of subjects with each pathogen and with strictly quantified bacterial counts were available in the current study, further investigation will be necessary to confirm these observations.
The remarkably strong correlation we observed between lavage IL-8 levels and neutrophil counts (figure 2) is in agreement with previous reports [7, 26] . IL-8 accounts for most of the neutrophil chemotactic activity in sputa from CF patients [8] . The predominant sources of IL-8 in the CF airway are not well defined but probably include epithelial cells [9, 27, 28] , macrophages [7] , and neutrophils themselves [29] . Furthermore, activated neutrophils produce elastase and oxidants, which stimulate epithelium to produce IL-8 [27, 28] . Interactions between these cell types are thus likely to be complex. It has been suggested that a feedback mechanism exists involving activated neutrophils, frustrated phagocytosis of bacteria, and epithelial IL-8, resulting in an equilibrium of persistent infection and inflammation in CF airways [30] ; however, it is unclear which factors are responsible for maintaining this equilibrium at a relatively high level in CF. Our data suggest that the neutrophil response to bacteria in the lower airways of children with CF is either excessive (e.g., due to overproduction of IL-8 by cells in the airways) or ineffective in clearing bacteria.
Another factor potentially capable of maintaining inflammation was suggested by a recent study in which BALF IL-IO levels from adult CF patients were significantly reduced compared with those in age-matched healthy controls [9] . The authors speculated that down-regulation of production of this antiinflammatory cytokine by airway epithelium may play a role in perpetuating inflammation in CF, a conclusion supported by immunohistochemical evidence. However, although there was a statistically insignificant tendency for nasal IL-IO levels to be lower in CF patients (table 3) , BALF levels of IL-IO clearly did not differ between the 4 groups in our study. Our data, when expressed as picograms per milliliter of epithelial lining fluid, matched the healthy control range in the study of Bonfield et al. [9] and thus do not support down-regulation of this cytokine in early childhood. The discrepancy between the two studies might be related to age or to chronicity of inflam- mation; alternatively, lack of increased IL-IO in the face of markedly increased inflammation such as we observed may itself be abnormal. Further investigation of the role of ILlOin airway neutrophil trafficking and the effects of chronic inflammation on epithelial cytokine production may be necessary before the results of these studies can be fully interpreted. Subjects in our uninfected control group had total cell counts in the normal range, as defined by a recent study of children with no known lower airway disease undergoing bronchoscopic evaluations for stridor [31] . These subjects had modest elevations in the percent neutrophils (average, 10.7%) on HALF cell differentials, consistent with the presence of lower respiratory symptoms as indications for bronchoscopy. Nevertheless, among uninfected subj ects, our HALF data for neutrophils (table 5) and IL-8 (table 6) are essentially consistent with the report of Khan et al. [7] in that HALF inflammatory markers in some uninfected children with CF are in a range intermediate between N -controls and CF + patients. Lack of infection was rigorously defined by Khan et al. as <200 cfu/mL of HALF, a result rarely found in our study, perhaps due to the older average age of our subjects, differences in bronchoscopic or bacterial culture techniques, or our study design, which involved only clinically indicated bronchoscopies. IL-8 levels, expressed as picograms per milliliter of BALF, in our N -and CF -groups were nevertheless in the same range as those in the analogous groups described by Khan et al. [7] and Balough et al. [32] . In our study and that of Khan et al. [7] , the data overlap between uninfected controls and uninfected CF subjects is considerable, suggesting that the inflammatory process is not necessarily present continuously after birth.
In support of this conclusion, Armstrong et al. [33] recently reported that HALF IL-8 levels and neutrophil counts did not differ between uninfected CF infants and control infants studied within the first 3 months of life. Analysis of our HALF data for uninfected CF patients in relation to recent medication history showed that the 2 subjects with no recent antibiotic treatment had much lower IL-8 levels than the 8 other uninfected CF children, who had all been treated with antibiotics within the 2 weeks preceding bronchoscopy. It is thus possible that increased airway inflammation in young uninfected CF patients represents the persistent sequela of recent infection. Alternatively, inflammation due to constitutive inflammatory processes or to undetected infectious or noninfectious stimuli could lead to symptoms (and hence, antibiotic treatment) independently of infection. Studies involving serial bronchoscopies in individual CF and control patients may be required to differentiate between these possibilities.
Our results give support to recent observations that lung inflammation in CF is "early, sustained, and severe" [34] and further suggest that the pathogenesis of inflammation is associated with abnormal IL-8 and neutrophil responses to bacterial infection in the lower airways. These responses must now be better defined in relation to specific pathogens, using both in vivo studies and in vitro models capable of assessing the roles of different effector cells in the complex airway cytokine network. Determination of whether inflammation precedes infection in CF will likely require studies of infants with and without CF in the newborn period. Ultimately, the relationship of any inflammatory abnormality to altered ion transport and expression of CFTR must be elucidated to form a complete picture of the pathogenesis of CF.
